Bromoethane

Bromoethane

SCHEMBL28759154

CCBr.O=C(O)N1CCNCC1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA9 Q16790 1/20 0.45
CHKA P35790 1/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42
CHRNB3 Q05901 1/20 0.42
CHRNA6 Q15825 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
POLB P06746 1/20 0.37
HSD11B1 P28845 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
KMT2A Q03164 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM3 P20309 1/20 0.35
HPGD P15428 1/20 0.35
GNAI3 P08754 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL10396098 0.87 CA2 (0.45) CA2CA12CA1CA9CHKA
Methyl Alcohol SCHEMBL27675953 0.86 CA2 (0.52) CA2CA12CA1CA9CHKA
SCHEMBL6961568 0.86
SCHEMBL15319 0.86
SCHEMBL17100538 0.86 CA2 (0.56) CA2CA12CA1CA9CHKA
SCHEMBL27672090 0.86 CA2 (0.41) CA2CA12CA1CA9CHKA
Water SCHEMBL11193463 0.84 CA2 (0.54) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL125486 0.84 CA2 (0.54) CA2CA12CA1CA9CHKA
Ammonia Solution, Strong SCHEMBL4674734 0.84 CA2 (0.54) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL18116041 0.84 CA2 (0.54) CA2CA12CA1CA9CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1897946-A 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms WYETH CORP (US) 2007-01-17 CN disclosed